R. Chris Rathbun, Pharm.D., BCPS, AQ-ID

Prof & Chair

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47254

Fax (405) 271-6430

Office CPB 211

Email chris-rathbun@ouhsc.edu


Summary

Research interests are centered in the area of HIV infection and include optimization of antiretroviral therapy, evaluation of novel antiretroviral agents and treatment strategies, medication adherence with antiretroviral regimens, and pharmacokinetic/pharmacodynamics drug interactions among antiretrovirals.



Research

Infectious diseases.




Publications & Presentations

<< 6 7 8 9 10 > >>
    41. Clay P G, Rathbun C, Slater L N. Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia. JAMA : the journal of the American Medical Association. 1999; 281 : 130; author reply 131

    42. Mihm L B, Rathbun C, Resman-Targoff B H. Hyperkalemia associated with high-dose trimethoprim-sulfamethoxazole in a patient with the acquired immunodeficiency syndrome. Pharmacotherapy. 1995; 15 : 793-7

    43. Morrison Y Y, Rathbun C. Hantavirus pulmonary syndrome: the Four Corners disease. The Annals of pharmacotherapy. 1995; 29 : 57-65

    44. Morrison Y Y, Rathbun C, Huycke M M. Disseminated histoplasmosis mimicking Crohn's disease in a patient with the acquired immunodeficiency syndrome. The American journal of gastroenterology. 1994; 89 : 1255-7

    45. Rathbun C. Tratamiento con didanosina en pacientes con intolerancia a la zidovudina o cuyo tratamiento con esta ha fracasado. Annals of Pharmacotherapy (Spanish Edition). 1993; 1 : 125-9

<< 6 7 8 9 10 > >>



Grants

<< 1 2 3 4 5 >>
    11. Clinical Pharmacy Services. HHS. Start Date: 2017. End Date: 2017.

    12. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    13. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    14. HIV Adherence Services. State Agency. Start Date: 2016. End Date: 2017.

    15. Clinical Pharmacy Services. HHS. Start Date: 2016. End Date: 2016.

<< 1 2 3 4 5 >>



Awards and Honors


no results

Education

                                                                                            1.  Degree: BS. University of Minnesota, Duluth. Date: 2005.  

                                                                                            2.  Degree: Infectious Diseases Fellowship. University of Texas at Austin. Date: 1991.  

                                                                                            3.  Degree: PharmD. University of Minnesota, Mpls-St. Paul. Date: 1989.  




Administrative Assignments

                                                

    1. Role: Department Chairperson. Scope: Department. Date: 2012.

                                                

    2. Role: Department Vice-Chair. Scope: Department. Date: 2011.